When the Fundrise Innovation Fund (VCX) hit the NYSE on March 19, it didn’t just debut—it went absolutely bonkers. Shares rocketed from $31.25 to $575 in four trading days. That’s a 1,740% surge. Circuit breakers fired. Trading halts happened back-to-back. At peak insanity, investors were paying 30 times the actual value of what was inside the fund. Then reality showed up. Activist short-seller Citron posted a chart on March 26, and VCX collapsed 49% in a single day. Now it’s trading around $130—still a ridiculous 585% premium to its actual net asset value. The mania isn’t dead, but the easy money is gone. Here’s what everyone was actually buying: Anthropic, OpenAI, and SpaceX. Three of the most valuable private companies on Earth, all wrapped into one liquid security that retail investors could grab on Robinhood. The appeal is obvious—you can’t buy these companies directly, so VCX became the closest proxy. Scarcity created the premium. Excitement turbocharged it. But here’s the problem: scarcity is temporary. Liquidity is forever. The moment Anthropic, OpenAI, or SpaceX go public—and they will—the entire rationale for paying a premium evaporates. You’ll be holding a fund that owns assets you can now buy directly, without the markup. Success becomes the exit signal. The better these companies perform, the worse VCX’s premium looks. There’s also the supply bomb waiting to detonate. Most of VCX’s early investors are locked in at $19 per share. When those lockups expire, the selling pressure will be brutal. That’s not speculation—that’s math. VCX is transitioning from a narrative-driven asset (priced on scarcity and hype) to a financial asset (priced on actual value). Assets in that phase rarely hold extreme premiums. So how do you actually play the AI IPO wave without losing your mind? SuRo Capital (SSSS) is the original publicly traded venture fund. It holds OpenAI, CoreWeave, and 35 other AI infrastructure plays. Management says forward NAV could hit $13-$15 per share, but SSSS trades around $9.89. That’s a 25-30% discount to forward value. You’re getting mega-IPO exposure at a discount while VCX investors are paying 585% premiums next door. Destiny Tech100 (DXYZ) is VCX’s more rational cousin. It holds SpaceX (23% of assets), OpenAI, and Anthropic. DXYZ trades at a 33% premium to NAV—elevated, sure, but rational for a fund holding hard-to-access assets. Thirty-three percent versus 585% tells you everything. ERShares Private-Public Crossover ETF (XOVR) takes a hybrid approach: 85% public equities, 15% private holdings including SpaceX and Anduril Industries. XOVR trades at a discount to NAV. You get pre-IPO exposure packaged with diversified public companies, minus the concentrated risk. The AI mega-IPO story is real. The opportunity is enormous. But you don’t need to lose your capital to ride it. SSSS, DXYZ, and XOVR all carry standard pre-IPO risks—illiquidity, valuation uncertainty, lockup provisions. But they’re infinitely more rational than paying $130 for $19 worth of assets. The biggest gains in market history didn’t go to IPO day buyers. They went to people already inside when the doors opened. That window is still open. But don’t be the sucker paying 30x to get through it.
